Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor
US12122780B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2020 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | Feb 12, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are a pyrimidinyl group-containing tricyclic compound and applications thereof in preparing a cancer-treating medicament. Specifically disclosed are a compound as represented by formula (I), a pharmaceutically acceptable salt of same, or an isomer thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.